National Research Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de National Research.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	17.2%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Feb 20

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Dec 13

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Oct 01

The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested

Mar 21

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Feb 11

National Research (NASDAQ:NRC) Is Achieving High Returns On Its Capital

Nov 25

Is National Research (NASDAQ:NRC) A Risky Investment?

Nov 02

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como National Research no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:NRC - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2024	147	30	N/A	N/A	N/A
12/31/2023	149	31	22	38	N/A
9/30/2023	149	29	21	35	N/A
6/30/2023	148	29	21	35	N/A
3/31/2023	150	30	25	36	N/A
12/31/2022	152	32	26	36	N/A
9/30/2022	152	35	31	40	N/A
6/30/2022	152	36	32	39	N/A
3/31/2022	151	37	33	40	N/A
12/31/2021	148	37	41	46	N/A
9/30/2021	144	36	45	50	N/A
6/30/2021	140	36	47	52	N/A
3/31/2021	135	35	45	50	N/A
12/31/2020	133	37	37	41	N/A
9/30/2020	131	38	33	36	N/A
6/30/2020	130	36	35	39	N/A
3/31/2020	130	36	35	39	N/A
12/31/2019	128	32	36	41	N/A
9/30/2019	126	31	38	43	N/A
6/30/2019	124	30	32	38	N/A
3/31/2019	120	31	33	39	N/A
12/31/2018	120	30	34	40	N/A
9/30/2018	119	29	26	33	N/A
6/30/2018	118	26	31	36	N/A
3/31/2018	118	24	23	28	N/A
12/31/2017	118	23	N/A	28	N/A
9/30/2017	116	22	N/A	30	N/A
6/30/2017	114	23	N/A	26	N/A
3/31/2017	112	21	N/A	31	N/A
12/31/2016	109	20	N/A	27	N/A
9/30/2016	107	21	N/A	25	N/A
6/30/2016	106	20	N/A	24	N/A
3/31/2016	104	19	N/A	25	N/A
12/31/2015	102	17	N/A	22	N/A
9/30/2015	101	16	N/A	20	N/A
6/30/2015	100	16	N/A	24	N/A
3/31/2015	99	16	N/A	23	N/A
12/31/2014	99	18	N/A	26	N/A
9/30/2014	97	18	N/A	25	N/A
6/30/2014	95	17	N/A	25	N/A
3/31/2014	94	16	N/A	21	N/A
12/31/2013	93	15	N/A	19	N/A
9/30/2013	92	15	N/A	21	N/A
6/30/2013	91	15	N/A	17	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de NRC es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de NRC crezcan más rápidamente que el mercado US

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de NRC crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de NRC crezcan más rápidamente que el mercado de US.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de NRC crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de NRC se prevé que sea elevada dentro de 3 años.

National Research Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

First quarter 2024 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2023)

National Research Corporation Declares a Quarterly Cash Dividend, Payable on July 15, 2024

National Research Corporation to Report Q1, 2024 Results on May 07, 2024

National Research Corporation, Annual General Meeting, May 08, 2024

Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

Upcoming dividend of US$0.12 per share

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Dividend of US$0.12 announced

National Research Corporation Announces the Retirement of Kevin Karas as Chief Financial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$1.26 (vs US$1.28 in FY 2022)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 15, 2024

National Research Corporation to Report Q4, 2023 Results on Feb 13, 2024

National Research Corporation Announces Executive Appointments

Insider recently sold US$15m worth of stock

Upcoming dividend of US$0.12 per share at 1.2% yield

Founder recently sold US$2.3m worth of stock

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

New minor risk - Insider selling

National Research Corporation Declares Quarterly Dividend, Payable on January 12, 2024

Founder notifies of intention to sell stock

Third quarter 2023 earnings released: EPS: US$0.32 (vs US$0.34 in 3Q 2022)

National Research Corporation to Report Q3, 2023 Results on Nov 07, 2023

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Upcoming dividend of US$0.12 per share at 1.0% yield

Upcoming dividend of US$1.00 per share at 1.1% yield

National Research Corporation Declares Special Dividend, Payable on September 22, 2023

National Research Corporation Declares Quarterly Dividend, Payable on October 13, 2023

Second quarter 2023 earnings released: EPS: US$0.30 (vs US$0.33 in 2Q 2022)

National Research Corporation to Report Q2, 2023 Results on Aug 01, 2023

We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Upcoming dividend of US$0.12 per share at 1.9% yield

Founder recently sold US$1.5m worth of stock

Founder recently sold US$954k worth of stock

Founder recently sold US$1.3m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on July 14, 2023

Why We Like The Returns At National Research (NASDAQ:NRC)

First quarter 2023 earnings released: EPS: US$0.28 (vs US$0.34 in 1Q 2022)

Founder recently sold US$59k worth of stock

Chief Operating Officer recently sold US$1.1m worth of stock

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Upcoming dividend of US$0.12 per share at 1.9% yield

Senior VP of Finance recently sold US$544k worth of stock

Founder recently sold US$292k worth of stock

Full year 2022 earnings released: EPS: US$1.28 (vs US$1.47 in FY 2021)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 14, 2023

National Research Corporation to Report Q4, 2022 Results on Feb 14, 2023

Founder recently sold US$259k worth of stock

Founder exercised options to buy US$439k worth of stock.

Upcoming dividend of US$0.12 per share

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corporation Declares Quarterly Dividend, Payable on January 13, 2023

Third quarter 2022 earnings released: EPS: US$0.34 (vs US$0.38 in 3Q 2021)

Founder recently sold US$1.8m worth of stock

Founder recently sold US$1.8m worth of stock

Chief Operating Officer exercised options and sold US$339k worth of stock

Upcoming dividend of US$0.24 per share

National Research Corp: Market Is Discounting These Key Factors

Founder recently sold US$3.9m worth of stock

National Research Corporation Declares Quarterly Dividend, Payable on October 14, 2022

National Research declares $0.24 dividend

Now 20% undervalued

National Research GAAP EPS of $0.33, revenue of $37.3M

National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Upcoming dividend of US$0.24 per share

Founder recently sold US$8.9m worth of stock

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

National Research Corporation Announces Quarterly Dividend, Payable on July 15, 2022

National Research Corporation Announces Appointment to Board of Directors

National Research Corp.: Quality/Low Risk On Sale

First quarter 2022 earnings released: EPS: US$0.34 (vs US$0.36 in 1Q 2021)

Founder recently sold US$141k worth of stock

Founder recently sold US$141k worth of stock

Founder recently sold US$331k worth of stock

National Research Corporation, Annual General Meeting, May 18, 2022